Vasculitis--diagnosis and treatment.
Gatenby
P A
PA
Canberra Clinical School, University of Sydney, The Canberra Hospital, Woden, ACT.
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D019268:Antibodies, Antineutrophil Cytoplasmic / Q000097:blood / Q000145:classification; D002648:Child; D005260:Female; D013700:Giant Cell Arteritis / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D014890:Granulomatosis with Polyangiitis / Q000453:epidemiology / Q000628:therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009080:Mucocutaneous Lymph Node Syndrome / Q000175:diagnosis / Q000209:etiology; D010488:Polyarteritis Nodosa / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D011239:Prednisolone / Q000627:therapeutic use; D013625:Takayasu Arteritis / Q000175:diagnosis / Q000628:therapy; D006113:United Kingdom; D014657:Vasculitis / Q000145:classification / Q000175:diagnosis / Q000628:therapy
D000893:Anti-Inflammatory Agents; D019268:Antibodies, Antineutrophil Cytoplasmic; D007166:Immunosuppressive Agents; D011239:Prednisolone